Zimmer Biomet Mirrors Medtronic's Robotics Move With Medtech SA
Zimmer Biomet will gain through a $130m deal a spine-surgery robot that may be able to compete in the emerging minimally invasive spine surgery segment. The technology will also complement Zimmer Biomet’s other recent acquisition in spine surgery devices.
You may also be interested in...
Market Intel: Rivals Catching Up To Intuitive Surgical In Fast-Growing, Fast-Innovating Robotic-Assisted Devices Market
The global market for robotically assisted systems (RAS) is expected to reach $5.3bn by 2021, a CAGR of 11.7%. Meddevicetracker expects this hot market, long-dominated by Intuitive Surgical's da Vinci systems, to see rising competition from innovative companies developing robotic systems that are smaller, portable and less costly and offer surgeons innovative features that allow them to perform even more precise and user-friendly, complex surgeries. In this feature, we'll take a closer look at the overall market, highlighting the competitive landscape as well as limiters and growth opportunities. We'll also take a deep dive into RAS systems and their applications. Surgeons of various specialties provide key insights about the pros and cons of different systems.
Q3 medtech financing doubled in dollar volume to $3 billion, with debt offerings again representing the majority of the aggregate; acquisitions totaled $5.3 billion, mainly due to Johnson & Johnson’s $4.3 billion buy of Abbott Medical Optics. Diagnostics financings, which brought in $85 million, continued to decline, but at $5 billion, acquisitions showed a slight increase over the previous quarter, with Danaher’s takeover of Cepheid accounting for most of the M&A volume.
The orthopedics giant is integrating a suite of products and services to help hospitals transition to value-based health-care payment models. The initial focus will be joint-replacement procedures, but Zimmer Biomet anticipates expanding the concept to spine surgery and other sectors.